ArticleCommunications medicine2026
Characterizing healthcare provider experiences delivering genomic testing in a Federally Qualified Health Center.
Article in Communications medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundTo maximize the potential benefits of genomic medicine for all, it is crucial to research and support the delivery of genomic medicine in under-researched healthcare settings.
methodsThis project investigated experiences of healthcare providers caring for low-resourced patients in a Federally Qualified Health Center in Phoenix, Arizona (FQHC) using a mixed-methods, cross-sectional case study. Interviews were conducted with 14 healthcare providers working in a FQHC, involved with delivering genomic testing (specifically, polygenic risk scores [PRS] and monogenic testing) to patients enrolled in the electronic Medical Records and Genomics (eMERGE) network, specifically the eMERGE IV study.
resultsProviders expressed a general confidence in genomic testing in practice. Quantitatively, most providers expressed confidence in communicating genomic test results to patients. However, qualitative findings emphasize time constraints, insufficient training, lack of human resources, and concerns for follow-up care and financial barriers, which are pronounced in FQHC settings.
conclusionsThe potential of genomic testing to improve patient outcomes is strong, but system-level support for providers is necessary to strive towards sustainable and equitable implementation of genomic medicine, particularly in FQHC and other under-resourced primary care settings.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.